As of 2025-03-21, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (108.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.72 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -1345.8%.
The range of the Relative Valuation is (89.77) - (140.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 49.2x | 41.4x |
| Forward P/E multiples | 26.9x - 50.1x | 34.6x |
| Fair Price | (89.77) - (140.65) | (108.63) |
| Upside | -1129.4% - -1713.0% | -1345.8% |
| Date | P/E |
| 2025-03-11 | -2.84 |
| 2025-03-10 | -2.85 |
| 2025-03-07 | -3.05 |
| 2025-03-06 | -2.98 |
| 2025-03-05 | -2.95 |
| 2025-03-04 | -2.84 |
| 2025-03-03 | -2.80 |
| 2025-02-28 | -2.97 |
| 2025-02-27 | -3.01 |
| 2025-02-26 | -2.96 |
| 2025-02-25 | -2.99 |
| 2025-02-24 | -3.05 |
| 2025-02-21 | -3.16 |
| 2025-02-20 | -3.20 |
| 2025-02-19 | -3.30 |
| 2025-02-18 | -3.24 |
| 2025-02-14 | -3.33 |
| 2025-02-13 | -3.35 |
| 2025-02-12 | -3.46 |
| 2025-02-11 | -3.43 |
| 2025-02-10 | -3.53 |
| 2025-02-07 | -3.57 |
| 2025-02-06 | -3.62 |
| 2025-02-05 | -3.60 |
| 2025-02-04 | -3.57 |
| 2025-02-03 | -3.52 |
| 2025-01-31 | -3.69 |
| 2025-01-30 | -3.84 |
| 2025-01-29 | -3.94 |
| 2025-01-28 | -3.66 |
| 2025-01-27 | -3.60 |
| 2025-01-24 | -3.69 |
| 2025-01-23 | -3.69 |
| 2025-01-22 | -3.68 |
| 2025-01-21 | -3.64 |
| 2025-01-17 | -3.59 |
| 2025-01-16 | -3.55 |
| 2025-01-15 | -3.56 |
| 2025-01-14 | -3.50 |
| 2025-01-13 | -3.86 |
| 2025-01-10 | -3.91 |
| 2025-01-08 | -3.89 |
| 2025-01-07 | -4.04 |
| 2025-01-06 | -4.12 |
| 2025-01-03 | -4.44 |
| 2025-01-02 | -4.33 |
| 2024-12-31 | -4.26 |
| 2024-12-30 | -4.27 |
| 2024-12-27 | -4.20 |
| 2024-12-26 | -4.51 |